Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly

NCT01951118 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

121

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease
Mild Cognitive Impairment
Delirium, Dementia, Amnestic, Cognitive Disorders

Interventions

DRUG: Donepezil

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]
[object Object]